The research group led by Peng Wu at the Max Planck Institute of Molecular Physiology has now developed a new type of “molecular eraser” targeting the mRNA of the cancer protein NRAS.
Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University’s Translational and Clinical Research Institute and the Department of Immunology at Cambridge University Hospitals NHS Foundation Trust, have identified an important driver of inflammatory bowel disease (IBD).
A new study in Nature by a team led by Doudna has uncovered a powerful new approach to selectively kill cancer cells using a CRISPR enzyme called Cas12a2.
Subtle Medical has announced FDA clearance for SubtleHD(CT), an AI-powered image enhancement solution designed to reduce noise and improve low contrast detectability across CT imaging
Learn more about Lassa virus, which continues to ravage parts of West Africa, and how combining a vaccine against it with rabies protection could address two major health concerns at once.
MIT researchers have designed an ultrasound system that creates a real-time 3D representation of the object being imaged.
The planned trial is expected to include 300 participants across two treatment arms.
The sensor expands Glean into wireless, catheter-free multi-channel urodynamics, targeting more comfortable and real-world bladder function testing.
DermaSensor announced today that it received Class IIb CE mark approval for its skin cancer detection device.
Karl Storz announced today that it received FDA clearance for the digital, camera-based Rubina Lens exoscope for open surgery.